Putnam Investments’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,218,678
Closed -$223M 1609
2014
Q4
$223M Sell
2,218,678
-6,132,012
-73% -$477M 0.46% 43
2014
Q3
$554M Buy
8,350,690
+918,268
+12% +$60.3M 1.17% 11
2014
Q2
$519M Buy
7,432,422
+621,940
+9% +$42.3M 1.12% 12
2014
Q1
$498M Buy
6,810,482
+1,402,131
+26% +$105M 1.13% 10
2013
Q4
$372M Buy
5,408,351
+1,346,410
+33% +$87.2M 0.89% 13
2013
Q3
$258M Buy
4,061,941
+1,478,661
+57% +$89.4M 0.69% 29
2013
Q2
$125M Buy
+2,583,280
New +$127M 0.36% 68

Putnam Investments's CBST Position: Q1 2015 in Review

Putnam Investments sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 2,218,678 shares — an estimated $223M sold.

Putnam Investments first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $554M in Q3 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Putnam Investments reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Putnam Investments sold 2,218,678 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $223M.
  • Putnam Investments first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Putnam Investments's CUBIST PHARMACEUTICALS INC position peaked at $554M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Putnam Investments's 13F filing for Q1 2015, filed 15 May 2015.